AAAAAA

   
Results: 1-10 |
Results: 10
Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha(2)-antiplasmin
Authors: Lee, AYY Fredenburgh, JC Stewart, RJ Rischke, JA Weitz, JI
Citation: Ayy. Lee et al., Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha(2)-antiplasmin, THROMB HAEM, 85(3), 2001, pp. 502-508
Conformational changes in thrombin when complexed by serpins
Authors: Fredenburgh, JC Stafford, AR Weitz, JI
Citation: Jc. Fredenburgh et al., Conformational changes in thrombin when complexed by serpins, J BIOL CHEM, 276(48), 2001, pp. 44828-44834
Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin
Authors: Liaw, PCY Becker, DL Stafford, AR Fredenburgh, JC Weitz, JI
Citation: Pcy. Liaw et al., Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor II in the presence of dermatan sulfate but not heparin, J BIOL CHEM, 276(24), 2001, pp. 20959-20965
Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase
Authors: Anderson, JAM Fredenburgh, JC Stafford, AR Guo, YS Hirsh, J Ghazarossian, V Weitz, JI
Citation: Jam. Anderson et al., Hypersulfated low molecular weight heparin with reduced affinity for antithrombin acts as an anticoagulant by inhibiting intrinsic tenase and prothrombinase, J BIOL CHEM, 276(13), 2001, pp. 9755-9761
Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator - A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator
Authors: Stewart, RJ Fredenburgh, JC Rischke, JA Bajzar, L Weitz, JI
Citation: Rj. Stewart et al., Thrombin-activable fibrinolysis inhibitor attenuates (DD)E-mediated stimulation of plasminogen activation by reducing the affinity of (DD)E for tissue plasminogen activator - A potential mechanism for enhancing the fibrin specificity of tissue plasminogen activator, J BIOL CHEM, 275(47), 2000, pp. 36612-36620
Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator
Authors: Stewart, RJ Fredenburgh, JC Leslie, BA Keyt, BA Rischke, JA Weitz, JI
Citation: Rj. Stewart et al., Identification of the mechanism responsible for the increased fibrin specificity of TNK-tissue plasminogen activator relative to tissue plasminogen activator, J BIOL CHEM, 275(14), 2000, pp. 10112-10120
Mechanism of action of plasminogen activators
Authors: Weitz, JI Stewart, RJ Fredenburgh, JC
Citation: Ji. Weitz et al., Mechanism of action of plasminogen activators, THROMB HAEM, 82(2), 1999, pp. 974-982
Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombininactivation by heparin cofactor II
Authors: Liaw, PCY Austin, RC Fredenburgh, JC Stafford, AR Weitz, JI
Citation: Pcy. Liaw et al., Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombininactivation by heparin cofactor II, J BIOL CHEM, 274(39), 1999, pp. 27597-27604
Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II
Authors: Becker, DL Fredenburgh, JC Stafford, AR Weitz, JI
Citation: Dl. Becker et al., Exosites 1 and 2 are essential for protection of fibrin-bound thrombin from heparin-catalyzed inhibition by antithrombin and heparin cofactor II, J BIOL CHEM, 274(10), 1999, pp. 6226-6233
Vasoflux, a new anticoagulant with a novel mechanism of action
Authors: Weitz, JI Young, E Johnston, M Stafford, AR Fredenburgh, JC Hirsh, J
Citation: Ji. Weitz et al., Vasoflux, a new anticoagulant with a novel mechanism of action, CIRCULATION, 99(5), 1999, pp. 682-689
Risultati: 1-10 |